References
- Angell W W, Angell J D, Kosek J C. Twelve-year experience with glutaraldehyde-preserved porcine xenografts. J Thorac Cardiovasc Surg 1982; 83: 493–502
- Björk V O, Henze A. Ten years experience with the Björk-Shiley tilting disc valve. J Thorac Cardiovasc Surg 1979; 78: 331–42
- Daenan W, Nevelsteen A, van Caulwelaert P, de Maesschalk E, Willems J, Stalpaert G. Nine years experience with the Björk-Shiley prosthetic valve: Early and late results of 932 replacements. Ann Thorac Surg 1983; 35: 651–63
- BMDP-statistical software, W J Dixon, M B Brown, L Engelman, et al. University of California Press, Berkeley, Los Angeles, London 1981; 1–726
- Fernandez J, Samuel A, Yang S S, et al. Late thrombosis of the Björk-Shiley prosthesis. Chest 1976; 70: 12–16
- Fuster V, Pumphrey C W, McGoon M D, Chesebro J H, Pluth J R, McGoon D C. Systemic thromboembolism in mitral and aortic Starr-Edwards prostheses: A 10–19 year follow-up. Circulation 1982; 66(Suppl I)157–61
- Gallo I, Ruiz B, Duran C MG. Five to eight year follow-up of patients with the Hancock cardiac bioprosthesis. J Thorac Cardiovasc Surg 1983; 86: 897–902
- Horstkotte D, Korfer R, Seipel L, Bircks W, Loogen F. Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation 1983; 68(Suppl II)175–84
- Lefrac E A, Starr A. Cardiac valve prostheses1st ed. Appleton-Century-Crofts, New York 1979; 67–117
- Lund O. Determinants of long-term survival after isolated aortic valve replacement. A ten to seventeen year follow-up. Tex Heart Inst J 1987; 14: 144–153
- Macmanus Q, Grunkemeier G L, Lambert L E, Starr A. Non-cloth-covered caged-ball prostheses. The second decade. J Thorac Cardiovasc Surg 1978; 76: 788–93
- Macmanus Q, Grunkemeier G L, Lambert L E, Teply J F, Harlan B J, Starr A. Year of operation as a risk factor in the late results of valve replacement. J Thorac Cardiovasc Surg 1980; 80: 834–41
- Magilligan D J, Lewis J W, Tilley B, Peterson E. The porcine bioprosthetic valve. Twelve years later. J Thorac Cardiovasc Surg 1985; 89: 499–507
- Martinell J, Salas J, de Vega N G, Moreno T, Fraile J, Rabago G. Thrombotic obstruction of the Björk-Shiley aortic valve prosthesis. Scand J Thor Cardiovasc Surg 1979; 13: 255–57
- Miller D C, Oyer P E, Mitchell R S, et al. Performance characteristics of the Starr-Edwards model 1260 aortic valve prosthesis beyond ten years. J Thorac Cardiovasc Surg 1984; 88: 193–207
- Oyer P E, Stinson E B, Reitz B A, Miller D C, Rossiter S J, Shumway N E. Long-term evaluation of the porcine xenograft bioprosthesis. J Thorac Cardiovasc Surg 1979; 78: 343–50
- Perier P, Bessou J P, Swanson J S, et al. Comparative evaluation of aortic valve replacement with Starr, Björk and porcine valve prostheses. Circulation 1985; 72(Suppl II)140–45
- Rubin J W, Moore H V, Hillson R F, Ellison R G. Thirteen year experience with aortic valve replacement. Am J Cardiol 1977; 40: 345–54
- Starr A. The Starr-Edwards valve. JACC 1985; 6: 899–903
- Starr A, Bonchek L I, Anderson R P, Wook J A, Chapman R D. Late complications of aortic valve replacement with cloth-covered composite-seat prostheses. Ann Thorac Surg 1975; 19: 289–300
- Teply J F, Grunkemeier G L, Sutherland H D, Lambert L E, Johnson V A, Starr A. The ultimate prognosis after valve replacement: An assessment at twenty years. Ann Thorac Surg 1981; 32: 111–19
- Wain W H, Drury P J, Ross D N. Aortic valve replacement with Starr-Edwards valves over 14 years. Ann Thorac Surg 1982; 33: 562–69
- Yoganathan A J, Corcoran W H, Harrison E C, Carl J R. The Björk-Shiley aortic prosthesis: Flow characteristics, thrombus formation and tissue overgrowth. Circulation 1978; 58: 70–76
- Yoganathan A P, Reamer H H, Corcoran W H, Harrison E C, Schulman I A, Parnassus W. The Starr-Edwards ball valve: Flow characteristics, thrombus formation, and tissue overgrowth. Artif Org 1981; 5: 6–17